Company Filing History:
1 out of 137 
1 out of 70 
1 out of 113 
Years Active: 2024
Title: Akira Yamauchi: Innovator in Cancer Research
Introduction
Akira Yamauchi is a notable inventor based in Kurashiki, Japan. He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on developing effective treatments for cancer metastasis and inflammatory diseases.
Latest Patents
Yamauchi holds a patent for an "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The pharmaceutical composition contains an antibody or an antibody fragment that has antigen-binding activity for the S100A8/A9 heterodimer. This invention blocks the interaction between S100A8/A9 and its receptors, thereby strongly suppressing cancer metastasis both in vitro and in vivo, or alleviating inflammation. The anti-S100A8/A9 antibody can significantly impact cancer treatment and inflammatory conditions.
Career Highlights
Throughout his career, Akira Yamauchi has worked at prestigious institutions such as Okayama University and Niigata University. His research has been pivotal in advancing the understanding of cancer biology and therapeutic interventions.
Collaborations
Yamauchi has collaborated with notable colleagues, including Masakiyo Sakaguchi and Shinichi Toyooka. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Akira Yamauchi's work exemplifies the intersection of innovation and medical research. His contributions to the development of the anti-S100A8/A9 antibody represent a significant advancement in the fight against cancer and inflammatory diseases. His ongoing research continues to inspire future innovations in the field.